Hen-Wei Wei

Dr. Hen-Wei Wei


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2010 in Oncogene
Verified
Journal Article
Closed access
CLC-C Lee
C-C Lee
HJH-J Jan
H-J Jan
JLJ-H Lai
J-H Lai
HMH-I Ma
H-I Ma
Dueng-Yuan HuengDueng-Yuan Hueng
Dueng-Yuan Hueng
HLH-M Lee
H-M Lee

23 December 2009 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
HJHsun-Jin Jan
Hsun-Jin Jan
CLChin-Cheng Lee
Chin-Cheng Lee
YSYung-Luen Shih
Yung-Luen Shih
DHDueng-Yuan Hueng
Dueng-Yuan Hueng
HMHsin-I Ma
Hsin-I Ma
HLHorng-Mo Lee
Horng-Mo Lee
Human malignant glioma cells are characterized by local invasion. In the present study, we investigated the role of osteopontin (OPN) in the invasiveness of human glioma cells isolated from grade IV tumors. We found that the expression levels of OPN in these cell lines paralleled matrix metalloproteinase-2 (MMP-2) expression and cell invasiveness potential. When U87MG glioma cells (with a high-OPN expression level) were stably transformed with specific small hairpin RNA to knock down OPN expression, MMP-2 secretion, cell invasiveness, and tumor growth in implanted brains were dramatically reduced. Conversely, forced expression of OPN in GBM-SKH glioma cells (which expressed OPN at a low level) increased MMP-2 secretion, enhanced cell invasiveness, and increased tumor growth in a rodent xenograft model. Expression of OPN was associated with increased expression of vimentin and decreased expression of glial fibrillary acidic protein. Treatment of glioma cells with 5-aza-2′-deoxycytidine (5-aza-dC) suppressed OPN expression in a concentration-dependent manner. Suppression of OPN expression by 5-aza-dC was associated with reductions in MMP-2 secretion, vimentin expression, cell invasion, intravasation, and tumor growth. These data suggest that OPN may play important roles in regulating cell invasion in glioma cells and that 5-aza-dC may serve as a therapeutic agent for human gliomas.

1 January 2015 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
SCShao-Kuang Chang
Shao-Kuang Chang
DLDan-Yuan Lo
Dan-Yuan Lo
HWHen-Wei Wei
Hen-Wei Wei
HKHung-Chih Kuo
Hung-Chih Kuo
This study determined the antimicrobial resistance profiles of Escherichia coli isolates from dogs with a presumptive diagnosis of urinary tract infection (UTI). Urine samples from 201 dogs with UTI diagnosed through clinical examination and urinalysis were processed for isolation of Escherichia coli. Colonies from pure cultures were identified by biochemical reactions (n=114) and were tested for susceptibility to 18 antimicrobials. The two most frequent antimicrobials showing resistance in Urinary E. coli isolates were oxytetracycline and ampicillin. Among the resistant isolates, 17 resistance patterns were observed, with 12 patterns involving multidrug resistance (MDR). Of the 69 tetracycline-resistant E. coli isolates, tet(B) was the predominant resistance determinant and was detected in 50.9% of the isolates, whereas the remaining 25.5% isolates carried the tet(A) determinant. Most ampicillin and/or amoxicillin-resistant E. coli isolates carried blaTEM-1 genes. Class 1 integrons were prevalent (28.9%) and contained previously described gene cassettes that are implicated primarily in resistance to aminoglycosides and trimethoprim (dfrA1, dfrA17-aadA5). Of the 44 quinolone-resistant E. coli isolates, 38 were resistant to nalidixic acid, and 6 were resistant to nalidixic acid, ciprofloxacin and enrofloxacin. Chromosomal point mutations were found in the GyrA (Ser83Leu) and ParC (Ser80Ile) genes. Furthermore, the aminoglycoside resistance gene aacC2, the chloramphenicol resistant gene cmlA and the florfenicol resistant gene floR were also identified. This study revealed an alarming rate of antimicrobial resistance among E. coli isolates from dogs with UTIs.

1 September 2008 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YLYu-Min Lin
Yu-Min Lin
HJHsun-Jin Jan
Hsun-Jin Jan
CLChin-Cheng Lee
Chin-Cheng Lee
HTHsiao-Yi Tao
Hsiao-Yi Tao
YSYu-Lueng Shih
Yu-Lueng Shih
HLHorng-Mo Lee
Horng-Mo Lee

1 December 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
WCWei-Lu Chen
Wei-Lu Chen
HWHen-Wei Wei
Hen-Wei Wei
WCWen-Zan Chiu
Wen-Zan Chiu
CKChing-Hui Kang
Ching-Hui Kang
TLTing-Han Lin
Ting-Han Lin
HLHorng-Mo Lee
Horng-Mo Lee

1 January 2004 in Asian-Australasian Journal of Animal Sciences
Verified
Journal Article
Open access
PDF file
DLDer-Nan N Lee
Der-Nan N Lee
YCYeong-Hsiang Cheng
Yeong-Hsiang Cheng
YCYu-Shuan Chuang
Yu-Shuan Chuang
JSJiing-Lin Shive
Jiing-Lin Shive
YLYuh-Ming Lian
Yuh-Ming Lian
CCC J Y Chang
C J Y Chang
Three experiments were conducted to evaluate the effects of taurine (Tau) supplements on broiler growth performance, serum constituents and antibody production. In Exp. 1, 3 day old chicks received a basal diet supplemented with Tau at 0, 0.10, 0.20, 0.30 or 0.40% for 6 weeks. Although dietary Tau supplementing at 0.30 or 0.40% enhanced feed conversion and reduced feed consumption during 0 to 3 weeks (p<0.05), neither serum total cholesterol or anti-Newcastle disease virus (NDV) titer were affected. In Exp. 2, dietary Tau supplement at 0.25-0.75% enhanced feed conversion of broilers during 0 to 3 weeks, but daily gain and feed consumption were not affected. The 0.75% Tau supplement group displayed lower serum total cholesterol at 6 weeks (p<0.05) comparing with the control group but no difference in anti-NDV titers. In Exp. 3, broilers were treated with dietary Tau of 0 or 0.50% combined with low (0/0%), medium (0.18/0.08%), or high (0.36/0.16%) methionine (Met) levels for 6 weeks (0 to 3/3 to 6 weeks). The addition of Met significantly improved daily gain and feed conversion of broilers during 0 to 3 weeks (p<0.01). Dietary Tau interacted significantly with Met on daily gain and feed consumption. Broiler serum amino acids revealed that Met supplements only increased serum Met level, but only serum Tau level was enhanced as given dietary Tau supplementation. The broilers receiving Tau normalized serum triglycerides level by feeding with the low Met diet and tended to display higher anti-NDV titers (p<0.10). The experimental results suggest that the growth response obtained by Tau supplements results partly from interactions with sulfur amino acids. However, the modulation of the broiler lipid metabolism may be responsible for dietary Tau.